Myto Health’s technology platform and tools allow discovery development of drugs, nutraceuticals, and diagnostic tools to promote mitochondrial health, to uncover susceptibility to neurodegeneration and to help clinicians to select a patient population that responds to UPS mitochondrial targeting therapies (personalized medicine). We have created opportunities for establishing collaborations and partnerships with companies as well as academic laboratories.